$237.98
0.340.14%
At close: May 19, 5:00 PM EST
$237.98
N/A
After Hours: 4:00 PM EST
Ascendis Pharma AS Earnings Estimates
ASNDNASDAQ
Ascendis Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ASND
Ascendis Pharma (ASND) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $0.68 and quarterly revenue of $359.86M.
In the most recent quarter (Q1), Ascendis Pharma reported EPS of $0.32, beating estimates of $0.21 by 0.52%. Revenue came in at $288.77M, missing the estimate of $318.05M by 0.09%.
Over the last 4 quarters, Ascendis Pharma has averaged an EPS surprise of 3.10% and a revenue surprise of 0.05%.
Earnings Date
Aug 6
EPS Estimate
$0.680
Quarterly Revenue Estimate
$359.86M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$865.78M
Ascendis Pharma Earnings History
Analyze the earnings history of Ascendis Pharma using advanced sorting and filters.
Loading calendar...
Ascendis Pharma (ASND) Earnings Per Share
The chart below shows Ascendis Pharma's reported EPS compared to analyst estimates over recent quarters.
Ascendis Pharma (ASND) Revenue
The chart below shows Ascendis Pharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?
Ascendis Pharma (ASND) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Ascendis Pharma (NASDAQ:ASND)?
The Actual EPS was $0.32, which beat the estimate of $0.21.
What were Ascendis Pharma’s (NASDAQ:ASND) revenues?
The Actual Revenue was $288.77M, which missed the estimate of $318.05M.
